The World Health Organization (WHO) will make an assessment on the use of the Sputnik V vaccine after Russia provides a full package of documents on the drug, which will include data and conclusions on its quality, safety and efficacy, said Oleg Benesh, senior specialist of the immunization department of the WHO European Office.

"WHO continues to work actively with Russian representatives on the preparation of the full documentation package in order to evaluate the Sputnik V vaccine. We are now at the stage where we are awaiting the submission of the full package of documents from the relevant entities," TASS quoted Beneš as saying.

To date, Satellite V has been registered in 70 countries with a total population of more than 4 billion people, or half of the world's population. As part of the international promotion of the Sputnik V vaccine, RDIF has signed agreements with leading pharmaceutical companies in India, China, South Korea, Argentina, Mexico and several other countries to produce the drug.

Made in Russia // Made in Russia